Related Experiment Video
Updated: Aug 10, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Folate status, vascular disease and cognition in elderly Canadians
E M Ebly1, J P Schaefer, N R Campbell
1Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Alberta, Canada.
Age and Ageing
|January 12, 1999
Summary
Low serum folate levels in elderly individuals are linked to a higher risk of stroke and cognitive decline. This highlights the importance of monitoring folate status in older populations for better health outcomes.
Area of Science:
- Gerontology
- Nutritional Neuroscience
- Epidemiology
Background:
- Serum folate levels are crucial for overall health, particularly in the elderly population.
- Previous research suggests a link between nutrient deficiencies and age-related diseases.
- Understanding folate's role in cognitive function and vascular health is essential for preventative strategies.
Purpose of the Study:
- To investigate the association between serum folate levels and the prevalence of stroke.
- To examine the relationship between serum folate levels and cognitive impairment, peripheral vascular disease, and short-term mortality in the elderly.
- To identify potential clinical implications of low folate levels in older adults.
Main Methods:
- A cross-sectional and longitudinal analysis was conducted on 1171 participants aged 65 and older from the Canadian Study of Health and Aging.
- Serum folate levels were determined during clinical examinations.
- Statistical analyses compared folate status with clinical features, including stroke, cognitive status, and mortality.
Main Results:
- Low serum folate levels were significantly associated with an increased likelihood of stroke.
- Individuals with low folate levels were more prone to dementia, institutionalization, and depression.
- Cognitively impaired individuals with low folate showed poorer performance on cognitive tests and experienced more short-term memory issues.
Conclusions:
- Low serum folate is a significant risk factor for stroke in the elderly.
- Low folate levels were prevalent in various forms of dementia and correlated with indicators of poor nutritional status.
- These findings suggest that impaired nutritional intake may contribute to cognitive decline and other health issues in the elderly.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...